Medlive Technology Co., Ltd.

SHSC:2192 Stock Report

Market Cap: HK$6.7b

Medlive Technology Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Liping Tian

Chief executive officer

CN¥4.8m

Total compensation

CEO salary percentage35.8%
CEO tenure11.8yrs
CEO ownership1.1%
Management average tenureno data
Board average tenure6.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Liping Tian's remuneration changed compared to Medlive Technology's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

CN¥290m

Mar 31 2024n/an/a

CN¥266m

Dec 31 2023CN¥5mCN¥2m

CN¥242m

Sep 30 2023n/an/a

CN¥216m

Jun 30 2023n/an/a

CN¥189m

Mar 31 2023n/an/a

CN¥153m

Dec 31 2022CN¥7mCN¥2m

CN¥117m

Sep 30 2022n/an/a

CN¥83m

Jun 30 2022n/an/a

CN¥48m

Mar 31 2022n/an/a

CN¥44m

Dec 31 2021CN¥7mCN¥1m

CN¥41m

Sep 30 2021n/an/a

CN¥55m

Jun 30 2021n/an/a

CN¥70m

Mar 31 2021n/an/a

CN¥78m

Dec 31 2020CN¥816kCN¥816k

CN¥85m

Dec 31 2019CN¥756kCN¥756k

CN¥31m

Dec 31 2018CN¥736kCN¥736k

CN¥14m

Compensation vs Market: Liping's total compensation ($USD661.10K) is above average for companies of similar size in the Hong Kong market ($USD463.84K).

Compensation vs Earnings: Liping's compensation has been consistent with company performance over the past year.

CEO

Liping Tian (57 yo)

11.8yrs

Tenure

CN¥4,839,000

Compensation

Ms. Liping Tian is Chairwoman and Chief Executive Officer of Medlive Technology Co. Ltd. Ms. Tian has been Executive Director of Medlive Technology Co. Ltd since April 2013. She has been the executive dire...

Board Members

NamePositionTenureCompensationOwnership
Liping Tian
Chairwoman & CEO11.8yrsCN¥4.84m1.1%
HK$ 73.6m
Lixin Tian
President11.1yrsCN¥2.14m0.27%
HK$ 18.2m
Lijun Tian
VP, Deputy Head of Medical Information Science Research Unit & Executive Director11.1yrsCN¥2.04m0.21%
HK$ 14.3m
Xin Zhou
VP & Executive Director6.5yrsCN¥673.00kno data
Richard L. Yeh
Independent Non-Executive Director4yrsCN¥120.00kno data
Eiji Tsuchiya
Non-Executive Director11.1yrsno datano data
Jun Ma
Independent Non-Executive Director4yrsCN¥120.00kno data
Shan Wang
Independent Non-Executive Director4yrsCN¥120.00kno data
Kazutaka Kanairo
Non-Executive Director1.8yrsno datano data

6.5yrs

Average Tenure

55yo

Average Age

Experienced Board: 2192's board of directors are considered experienced (6.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/06 11:01
End of Day Share Price 2025/01/03 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medlive Technology Co., Ltd. is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhu ChenCitic Securities Co., Ltd.
Shuo SongCitic Securities Co., Ltd.
Justin KwokGoldman Sachs